TRANSITION TIMES
Subscribe
Home
Data Hub
Interim
Transition Management
Fractional
Tech
M&A
Announcements
Investigation
Search Articles
Data Hub
/
People
/
Matthew Henn
MH
Matthew Henn
President and Chief Scientific Officer
@
Seres Therapeutics
1
Mentions
First mentioned:
Mar 2026
Last mentioned:
Mar 2026
Career Trajectory
No transitions recorded yet.